Diseases' platforms in endemic regions

To consolidate and strengthen existing R&D capacity, promote scientific exchange, and facilitate access to new tools, DNDi works to foster collaborations among key actors in endemic countries, including health ministries, national disease control programmes, regulatory authorities, WHO, academia, and civil society groups, as well as clinicians and health professionals. Initiatives to utilize and strengthen research capacities in low- and middle-income countries and support networks of excellence to sustain public-interest R&D are central to DNDi’s virtual R&D model. They are also critical to realizing our ultimate objective of fostering new innovation ecosystems – driven by scientific leaders in affected countries – that can fundamentally change how R&D in the public interest is realised and delivered. Since 2003, DNDi has supported the creation and maintenance of four regional clinical research platforms: the Chagas Platform, the HAT Platform, the LEAP (Leishmaniasis East Africa Platform), and redeLEISH (Network of Investigators and collaborators in leishmaniasis).